In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells.

A Shablak; DE Gilham; RE Hawkins; E Elkord

doi:10.1517/14656566.2014.920824

In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells.

A Shablak, DE Gilham, RE Hawkins, E Elkord

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1489-1499
Number of pages	10
Journal	Expert opinion on pharmacotherapy
Volume	15
Issue number	11
DOIs	https://doi.org/10.1517/14656566.2014.920824
Publication status	Published - Aug 2014

Keywords

Antineoplastic Agents/*pharmacology
Apoptosis/*drug effects
Carcinoma, Renal Cell/drug therapy/pathology
Cell Line, Tumor
Cell Proliferation/drug effects
Drug Synergism
Humans
Indoles/*pharmacology
Interleukin-2/*pharmacology
Kidney Neoplasms/drug therapy/pathology
Lymphocytes/*drug effects/physiology
Pyrimidines/*pharmacology
Pyrroles/*pharmacology
Sulfonamides/*pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1517/14656566.2014.920824

http://www.ncbi.nlm.nih.gov/pubmed/24890457

Cite this

@article{5a8648c89af14f209772b6f9ad4ea06d,

title = "In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells.",

keywords = "Antineoplastic Agents/*pharmacology, Apoptosis/*drug effects, Carcinoma, Renal Cell/drug therapy/pathology, Cell Line, Tumor, Cell Proliferation/drug effects, Drug Synergism, Humans, Indoles/*pharmacology, Interleukin-2/*pharmacology, Kidney Neoplasms/drug therapy/pathology, Lymphocytes/*drug effects/physiology, Pyrimidines/*pharmacology, Pyrroles/*pharmacology, Sulfonamides/*pharmacology",

author = "A Shablak and DE Gilham and RE Hawkins and E Elkord",

year = "2014",

month = aug,

doi = "10.1517/14656566.2014.920824",

language = "English",

volume = "15",

pages = "1489--1499",

journal = "Expert opinion on pharmacotherapy",

issn = "1465-6566",

publisher = "Taylor & Francis",

number = "11",

}

TY - JOUR

T1 - In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells.

AU - Shablak, A

AU - Gilham, DE

AU - Hawkins, RE

AU - Elkord, E

PY - 2014/8

Y1 - 2014/8

KW - Antineoplastic Agents/pharmacology

KW - Apoptosis/drug effects

KW - Carcinoma, Renal Cell/drug therapy/pathology

KW - Cell Line, Tumor

KW - Cell Proliferation/drug effects

KW - Drug Synergism

KW - Humans

KW - Indoles/pharmacology

KW - Interleukin-2/pharmacology

KW - Kidney Neoplasms/drug therapy/pathology

KW - Lymphocytes/drug effects/physiology

KW - Pyrimidines/pharmacology

KW - Pyrroles/pharmacology

KW - Sulfonamides/pharmacology

U2 - 10.1517/14656566.2014.920824

DO - 10.1517/14656566.2014.920824

M3 - Article

SN - 1465-6566

VL - 15

SP - 1489

EP - 1499

JO - Expert opinion on pharmacotherapy

JF - Expert opinion on pharmacotherapy

IS - 11

ER -